Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID II Trial
2023-503717-30-00Phase 4Authorised
- Sponsor
- Medical University of Vienna
- Start
- Jun 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD), post-operative cognitive decline (POCD) and postoperative nausea and vomiting (PONV) comparing Desflurane (Suprane) arm, Sevoflurane (Sevorane) arm and Propofol arm (3 arms). Planned start Jun 2023; status: authorised.
02
Drugs
propofolsevofluranedesflurane
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2023-503717-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503717-30-00.